The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae

被引:26
作者
George, J [1 ]
Morrissey, I [1 ]
机构
[1] UNIV E LONDON,CHEMOTHERAPY RES UNIT,LONDON E15 4LZ,ENGLAND
关键词
D O I
10.1093/jac/39.6.719
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The bactericidal activity of levofloxacin was compared with that of four other quinolones and one cephalosporin against four strains of Streptococcus pneumoniae with varying degrees of penicillin G susceptibility. Levofloxacin was found to be the most bactericidal quinolone at its optimum bactericidal concentration, followed by ofloxacin, ciprofloxacin, sparfloxacin and D-ofloxacin, in that order. There was no correlation between quinolone-susceptibility and penicillin-susceptibility with any quinolone tested. To allow a comparison between the bactericidal activity of the quinolones and cefotaxime to be made a bactericidal index was used.(1) Against two penicillin-sensitive pneumococci and a penicillin-intermediate pneumococcus, cefotaxime was the most potent antibacterial agent tested, followed by levofloxacin. However, against the penicillin-resistant pneumococcus, levofloxacin was considerably more potent than cefotaxime. The remaining quinolones tested were inferior to levofloxacin. Levofloxacin has enhanced activity against pneumococci compared with clinically available quinolones. In addition, levofloxacin may be the future quinolone of choice in the treatment of penicillin-resistant pneumococci.
引用
收藏
页码:719 / 723
页数:5
相关论文
共 23 条
  • [1] APPELBAUM PC, 1977, LANCET, V2, P995
  • [2] ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW
    APPELBAUM, PC
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) : 77 - 83
  • [3] Bactericidal effect of sparfloxacin alone and in combination with amoxicillin against Streptococcus pneumoniae as determined by kill-kinetic studies
    Barakett, V
    Lesage, D
    Delisle, F
    Richard, G
    Petit, JC
    [J]. INFECTION, 1996, 24 (01) : 22 - 25
  • [4] CHOW AT, 1992, 4 INT S NEW QUIN MUN, P136
  • [5] LEVOFLOXACIN A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETICS AND THERAPEUTIC EFFICACY
    DAVIS, R
    BRYSON, HM
    [J]. DRUGS, 1994, 47 (04) : 677 - 700
  • [6] INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF LEVOFLOXACIN (L-OFLOXACIN), AN OPTICALLY-ACTIVE OFLOXACIN
    FU, KP
    LAFREDO, SC
    FOLENO, B
    ISAACSON, DM
    BARRETT, JF
    TOBIA, AJ
    ROSENTHALE, ME
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) : 860 - 866
  • [7] MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF CIPROFLOXACIN IN NORMAL VOLUNTEERS
    GONZALEZ, MA
    URIBE, F
    MOISEN, SD
    FUSTER, AP
    SELEN, A
    WELLING, PG
    PAINTER, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) : 741 - 744
  • [8] EMERGENCE OF MULTIPLY RESISTANT PNEUMOCOCCI
    JACOBS, MR
    KOORNHOF, HJ
    ROBINSBROWNE, RM
    STEVENSON, CM
    VERMAAK, ZA
    FREIMAN, I
    MILLER, GB
    WITCOMB, MA
    ISAACSON, M
    WARD, JI
    AUSTRIAN, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (14) : 735 - 740
  • [9] PHARMACODYNAMICS OF LEVOFLOXACIN, OFLOXACIN, AND CIPROFLOXACIN, ALONE AND IN COMBINATION WITH RIFAMPIN, AGAINST METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN AN IN-VITRO INFECTION MODEL
    KANG, SL
    RYBAK, MJ
    MCGRATH, BJ
    KAATZ, GW
    SEO, SM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) : 2702 - 2709
  • [10] COMPARATIVE PHARMACOKINETICS OF CEFOPERAZONE, CEFOTAXIME, AND MOXALACTAM
    KEMMERICH, B
    LODE, H
    BELMEGA, G
    JENDROSCHEK, T
    BORNER, K
    KOEPPE, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (03) : 429 - 434